北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 血液内科  > 期刊论文
学科主题: 临床医学
题名:
Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units
作者: Yin Yue; Ren Han-yun; Cen Xin-an; Qiu Zhi-xiang; Ou Jin-ping; Wang Wen-sheng; Wang Mang-ju; Xu Wei-lin; Wang Li-hong; Li Yuan; Dong Yu-jun
关键词: double-unit umbilical cord blood transplantation ; unrelated donor ; leukemia
刊名: CHINESE MEDICAL JOURNAL
发表日期: 2011-08-20
DOI: 10.3760/cma.j.issn.0366-6999.2011.16.003
卷: 124, 期:16, 页:2411-2416
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal
研究领域[WOS]: General & Internal Medicine
关键词[WOS]: ACUTE LYMPHOBLASTIC-LEUKEMIA ; BONE-MARROW ; HEMATOLOGICAL MALIGNANCIES ; QUANTITATIVE-DETERMINATION ; HOST DISEASE ; FOLLOW-UP ; CHILDREN ; ENGRAFTMENT ; DONORS ; RECIPIENTS
英文摘要:

Background Wide application of umbilical cord blood transplantation (UCBT) in adult patients is limited by low cell-dose available in one umbilical cord blood (UCB) unit. The aim of this study was to investigate the safety and long-term outcomes of UCBT from unrelated donors in adult and adolescent patients with leukemia.

Methods Thirteen patients with leukemia received double-unit UCBT with human leukocyte antigen (HLA) mismatched at 0-2 loci. We analyzed the engraftment, graft-versus-host disease (GVHD) and survival. Results Twelve evaluable patients (92.3%) had neutrophil and platelet engraftment at a median of 21 days (range, 16-38 days) and 34 days (range, 25-51 days), respectively. At day 30, engraftment was derived from one donor in 8 patients (66.7%, 95% Cl 40.0%-93.4%), and from both donors in 4 patients (33.3%, 95% Cl 6.7%-60.0%) with 1 unit predominated. Unit with larger nucleated cell (NC) dose would predominate in engraftment (P=0.039), whereas CD34(+) cell dose or HLA-match failed to demonstrate any relationship with unit predominance. Only one patient developed grade II acute graft-versus-host disease (aGVHD). Chronic GVHD (cGVHD) was observed in 2 of 11 patients who survived more than 100 days, and both were limited. The median follow-up after transplantation for the 13 patients was 45 months (range 1.5-121.0 months) and 72 months (range 41.0-121.0 months) for the 8 alive and with full donor chimerism. The 5-year cumulative disease free survival (DFS) was (61.5 +/- 13.5)%. Of the 13 patients, 5 patients died in 1 year and 1-year transplantation related mortality (TRM) was 23.1% (95% Cl 0.2%-46.0%).

Conclusion Double-unit UCBT from unrelated donors with HLA-mismatched at 0-2 loci may overcome the cell-dose barrier and be feasible for adults and adolescents with leukemia. Chin Med J 2011;124(16):2411-2416

语种: 英语
WOS记录号: WOS:000294584200003
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/52060
Appears in Collections:北京大学第一临床医学院_血液内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Hosp 1, Dept Hematol, Beijing 100034, Peoples R China

Recommended Citation:
Yin Yue,Ren Han-yun,Cen Xin-an,et al. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units[J]. CHINESE MEDICAL JOURNAL,2011,124(16):2411-2416.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yin Yue]'s Articles
[Ren Han-yun]'s Articles
[Cen Xin-an]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yin Yue]‘s Articles
[Ren Han-yun]‘s Articles
[Cen Xin-an]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace